These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5758674)

  • 1. [Conditions of action of thrombolytic agents in arterial obliteration].
    Courbier R; Baille Y; Juhan C; Goudard A; Tramier H; Boutros H; Henry E
    Ann Chir Thorac Cardiovasc; 1968 Apr; 7(2):597-604. PubMed ID: 5758674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic agents and substances with "minor fibrinolytic" effect].
    Verstraete M; Amery A
    Rev Atheroscler (Paris); 1968; 10(2):21-7. PubMed ID: 5759946
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical parameters and thrombolytic success in recent arterial occlusions.
    Verstraete M
    Scand J Clin Lab Invest Suppl; 1967; 99():190-2. PubMed ID: 4228464
    [No Abstract]   [Full Text] [Related]  

  • 4. [Association of surgical treatment and thrombolytics in acute arterial obliteration of the extremities].
    Courbier R
    Rev Atheroscler (Paris); 1968; 10(2):14-8. PubMed ID: 5759944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic and selective streptokinase therapy in arterial occlusions].
    Hess H
    Internist (Berl); 1982 Jul; 23(7):405-9. PubMed ID: 6213579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fluidifying action of 3(methyl-oxyethylamino)-2 oxypropyl-theophylline nicotinate (Vedrin)].
    Molino N; Belluardo C; Catalano S
    Minerva Cardioangiol; 1966 Feb; 14(2):85-8. PubMed ID: 5931706
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathologic anatomy of arteriosclerosis].
    Beneke G
    Med Klin; 1971 May; 66(20):729-36. PubMed ID: 4930165
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary clinical uses of aspirin as an anticoagu.ant. (Preliminary note)].
    Cavalieri U; Quadri A; Tammaro AE
    Policlinico Prat; 1970 Dec; 77(51):1666-70. PubMed ID: 5516120
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant therapy of peripheral arterial thrombosis.
    Hess H
    Thromb Diath Haemorrh Suppl; 1966; 21():371-6. PubMed ID: 5969875
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
    Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histopathological findings in 60 cases of disobliterated arterial obstructions].
    Stancanelli V; Nenci I; Rossotto P; Ruffo A
    Minerva Med; 1970 Oct; 61(79):4339-60. PubMed ID: 4099929
    [No Abstract]   [Full Text] [Related]  

  • 13. [The therapy of chronic arterial obliteration].
    Schnell D
    Ther Ggw; 1967 Feb; 106(2):174-84. PubMed ID: 5594286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Old-age changes in arteries of the arteriosclerosis obliterans type in the myocardium].
    Chumakova TG
    Arkh Patol; 1968; 30(9):30-5. PubMed ID: 5734145
    [No Abstract]   [Full Text] [Related]  

  • 15. [The action of a thrombolytic agent on bone consolidation: experimental animal study (author's transl)].
    Nosny P; Nosny Y; Richard A; Vian J
    Chirurgie; 1979; 105(10):881-4. PubMed ID: 544200
    [No Abstract]   [Full Text] [Related]  

  • 16. [6 attempts at thrombolytic treatment].
    Chedal J
    Rev Atheroscler (Paris); 1968; 10(2):28-9. PubMed ID: 5759947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
    Naito I
    Rinsho Ketsueki; 1984 Jul; 25(7):1027-35. PubMed ID: 6389929
    [No Abstract]   [Full Text] [Related]  

  • 18. [Humoral study of the therapeutic action of an arterial wall extract in arteriosclerotic obstructive arteriopathies].
    Citone G; Fazzini PF; Fiorani P; Faraglia V; Spartera C; Trovati A
    Minerva Med; 1970 Aug; 61(67):3499-506. PubMed ID: 5453989
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new case of retinal arterial obliteration repermeabilized with streptokinase].
    Coscas G; Samama M; Conard J; Limon S
    Bull Soc Ophtalmol Fr; 1970 Jan; 70(1):59-62. PubMed ID: 5453592
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetic arteriopathy. A new nosological entity between diabetic microangiopathy and atherosclerosis in diabetes].
    Pratesi F; Caramelli L
    Minerva Med; 1971 Jan; 62(9):390-1. PubMed ID: 5545797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.